Radiofrequency ablators represent 46.0% of the product category and cardiovascular disease treatment accounts for 25.0% of application demand in 2026. The ablation technology market was valued at USD 6.8 billion in 2025, is projected to reach USD 17.4 billion by 2036 and is forecast to post an 8.9% CAGR between 2026 and 2036.